Antibacterial filter PL2V series

plateletbedside

Clinically proven media technology Easy prime technology Enhanced ease of use High efficiency leucocyte removal Platelet recovery greater than 90% Minimal filter hold-up volume (5 mL after recovery) Reduction of anaphylatoxin (C3a) Bedside filtration of 3 to 6 units of platelet concentrate or an equivalent single donor platelet collection Features and Benefits Clinically proven media technology significantly reduces the risk of leucocyte associated transfusion complications such as microaggregates, alloimmunisation, febrile reactions, refractoriness to platelets, Cytomegalovirus and immunosuppression.* Ease of use has been significantly enhanced by the new filter design which provides: priming by gravity unique self levelling drip chamber allowing self priming of the filter and drip chamber new vented spike design to allow upstream of filter to drain following transfusion, maximising platelet recovery Dependably and efficiently delivers low leucocyte residuals, consistently averaging less than 2 x 105 per transfusion, affording the maximum patient protection against leucocyte related transfusion complications. Unique media allows reduction of anaphylatoxin C3a** which has been shown to elicit biological and pathological effects including anaphylaxis and immunosuppression.* Designed to filter 3 – 6 units of random donor unit pools or an equivalent volume of apheresis platelets. Haemonetics’s high technology filtration media, new recovery spike and low filter hold-up volume (5 mL after recovery) provides minimal loss of platelets, typically greater than 90% recovery, without the need for saline flushing.